clinical trial · NCT07925983
A Study to Assess How Intravenous and Subcutaneous Administrations of Trosunilimab Move Through the Body of Healthy Adult Participants
Healthy VolunteerTrosunilimabTrosunilimab
brief summary
The objective of this study is to assess the pharmacokinetic (PK), immunogenicity and safety following trosunilimab SC and trosunilimab IV doses in healthy adult participants.
started
Oct 13, 2026
primary completion
May 1, 2027
completion
May 1, 2027
last updated
Nov 9, 2026
official title
A Phase 1 Study in Healthy Subjects to Assess Pharmacokinetics Following Intravenous and Subcutaneous Administration of Trosunilimab
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol